These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38333188)

  • 1.
    Yang Y; He L; Xie Y; Zhu L; Wu J; Fan Y; Yang Y; Sun X
    Front Cell Dev Biol; 2023; 11():1276890. PubMed ID: 38333188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene correction of HBB mutations in CD34
    Antony JS; Latifi N; Haque AKMA; Lamsfus-Calle A; Daniel-Moreno A; Graeter S; Baskaran P; Weinmann P; Mezger M; Handgretinger R; Kormann MSD
    Mol Cell Pediatr; 2018 Nov; 5(1):9. PubMed ID: 30430274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
    Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
    Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
    Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
    Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology.
    Li L; Yi H; Liu Z; Long P; Pan T; Huang Y; Li Y; Li Q; Ma Y
    Stem Cell Res Ther; 2022 Mar; 13(1):102. PubMed ID: 35255977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient therapeutic gene editing of human hematopoietic stem cells.
    Wu Y; Zeng J; Roscoe BP; Liu P; Yao Q; Lazzarotto CR; Clement K; Cole MA; Luk K; Baricordi C; Shen AH; Ren C; Esrick EB; Manis JP; Dorfman DM; Williams DA; Biffi A; Brugnara C; Biasco L; Brendel C; Pinello L; Tsai SQ; Wolfe SA; Bauer DE
    Nat Med; 2019 May; 25(5):776-783. PubMed ID: 30911135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.
    Pavani G; Fabiano A; Laurent M; Amor F; Cantelli E; Chalumeau A; Maule G; Tachtsidi A; Concordet JP; Cereseto A; Mavilio F; Ferrari G; Miccio A; Amendola M
    Blood Adv; 2021 Mar; 5(5):1137-1153. PubMed ID: 33635334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.
    Tran NT; Graf R; Wulf-Goldenberg A; Stecklum M; Strauß G; Kühn R; Kocks C; Rajewsky K; Chu VT
    Mol Ther; 2020 Dec; 28(12):2621-2634. PubMed ID: 32822592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9.
    Wattanapanitch M
    Methods Mol Biol; 2021; 2211():193-211. PubMed ID: 33336279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods.
    Pattabhi S; Lotti SN; Berger MP; Singh S; Lux CT; Jacoby K; Lee C; Negre O; Scharenberg AM; Rawlings DJ
    Mol Ther Nucleic Acids; 2019 Sep; 17():277-288. PubMed ID: 31279229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Effects of Hematopoietic Stem Cell Derived From Gene-Edited Mice on β654-Thalassemia.
    Lu D; Gong X; Guo X; Chen Y; Zhu Y; Fang Y; Cai Q; Xu M; Yang H; Li D; Zeng Y; Zeng F
    Stem Cells; 2024 Mar; 42(3):278-289. PubMed ID: 38134938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells.
    Niu X; He W; Song B; Ou Z; Fan D; Chen Y; Fan Y; Sun X
    J Biol Chem; 2016 Aug; 291(32):16576-85. PubMed ID: 27288406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
    Bloomer H; Smith RH; Hakami W; Larochelle A
    Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection.
    Liu Y; Yang Y; Kang X; Lin B; Yu Q; Song B; Gao G; Chen Y; Sun X; Li X; Bu L; Fan Y
    Mol Ther Nucleic Acids; 2017 Mar; 6():57-67. PubMed ID: 28325300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia.
    Xu S; Luk K; Yao Q; Shen AH; Zeng J; Wu Y; Luo HY; Brendel C; Pinello L; Chui DHK; Wolfe SA; Bauer DE
    Blood; 2019 May; 133(21):2255-2262. PubMed ID: 30704988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting.
    Charlesworth CT; Camarena J; Cromer MK; Vaidyanathan S; Bak RO; Carte JM; Potter J; Dever DP; Porteus MH
    Mol Ther Nucleic Acids; 2018 Sep; 12():89-104. PubMed ID: 30195800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells.
    Ma N; Liao B; Zhang H; Wang L; Shan Y; Xue Y; Huang K; Chen S; Zhou X; Chen Y; Pei D; Pan G
    J Biol Chem; 2013 Nov; 288(48):34671-9. PubMed ID: 24155235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac.
    Xie F; Ye L; Chang JC; Beyer AI; Wang J; Muench MO; Kan YW
    Genome Res; 2014 Sep; 24(9):1526-33. PubMed ID: 25096406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.